172 related articles for article (PubMed ID: 14165678)
1. ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.
RATNOFF OD; CRUM JD
J Lab Clin Med; 1964 Mar; 63():359-77. PubMed ID: 14165678
[No Abstract] [Full Text] [Related]
2. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
DOKU HC; TAYLOR RG; SISE HS; BECKER R
J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
[No Abstract] [Full Text] [Related]
3. [DIAGNOSTIC PROBLEMS IN CASES OF HEMORRHAGE].
HORANYI M
Orv Hetil; 1964 Jun; 105():1119-23. PubMed ID: 14163246
[No Abstract] [Full Text] [Related]
4. Inhibitor of human blood coagulation elicited by thrombin.
Marciniak E
J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
[No Abstract] [Full Text] [Related]
5. FUNCTION OF AC-GLOBULIN AND LIPID IN BLOOD CLOTTING.
SEEGERS WH; COLE ER; AOKI N
Can J Biochem Physiol; 1963 Dec; 41():2441-61. PubMed ID: 14099702
[No Abstract] [Full Text] [Related]
6. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII).
Niwano H; Embury PB; Greenberg BD; Ratnoff OD
J Lab Clin Med; 1995 Feb; 125(2):251-6. PubMed ID: 7844473
[TBL] [Abstract][Full Text] [Related]
7. BLOOD COAGULATION. VII. COAGULATION II.
DUGDALE M
Memphis Mid South Med J; 1963 Jan; 38():19-22. PubMed ID: 14087826
[No Abstract] [Full Text] [Related]
8. [HAGEMAN FACTOR DEFICIENCY].
VERRASTRO T; COSTA MF; JAMRA M
Rev Hosp Clin Fac Med Sao Paulo; 1963; 18():511-6. PubMed ID: 14119075
[No Abstract] [Full Text] [Related]
9. [APROPOS OF HYPOPROCONVERTINEMIA].
GEIRO SB; KALUZHENKO RK
Klin Med (Mosk); 1963 Aug; 41():57-61. PubMed ID: 14086889
[No Abstract] [Full Text] [Related]
10. Laboratory diagnosis of congenital coagulation defects.
Lowe GD; Forbes CD
Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
[No Abstract] [Full Text] [Related]
11. THE DIAGNOSIS AND MANAGEMENT OF BLEEDING DISORDERS.
HOAK JC; CONNOR WE; WARNER ED
J Iowa Med Soc; 1964 Jul; 54():331-41. PubMed ID: 14157038
[No Abstract] [Full Text] [Related]
12. [PLATELET ADHESIVITY AND VISCOUS METAMORPHOSIS. STUDY IN VARIOUS HEMORRHAGIC DISEASES].
VERRASTRO T; COELHO E; JAMRA M
Rev Hosp Clin Fac Med Sao Paulo; 1963; 18():397-406. PubMed ID: 14116074
[No Abstract] [Full Text] [Related]
13. Prothrombin complex concentrates.
Penner JA
Bibl Haematol; 1977; 44():81-7. PubMed ID: 617787
[TBL] [Abstract][Full Text] [Related]
14. Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent.
Thorisdottir H; Ratnoff OD; Maniglia AJ
J Lab Clin Med; 1988 Oct; 112(4):481-6. PubMed ID: 3171356
[TBL] [Abstract][Full Text] [Related]
15. Prothrombin complex concentrates: preparation, properties, and clinical uses.
White GC; Lundblad RL; Kingdon HS
Curr Top Hematol; 1979; 2():203-44. PubMed ID: 318075
[No Abstract] [Full Text] [Related]
16. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
IDA M; TANAKA M
Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922
[No Abstract] [Full Text] [Related]
17. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
Dumenco LL; Everson B; Culp LA; Ratnoff OD
J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
[TBL] [Abstract][Full Text] [Related]
18. THE BIOLOGICAL DISAPPEARANCE RATE OF PROTHROMBIN, FACTORS VII, IX AND X FROM PLASMA IN HYPOTHYROIDISM, HYPERTHYROIDISM, AND DURING FEVER.
LOELIGER EA; VAN DER ESCH B; MATTERN MJ; HEMKER HC
Thromb Diath Haemorrh; 1964 Jan; 10():267-77. PubMed ID: 14113369
[No Abstract] [Full Text] [Related]
19. [Blood coagulation disorders caused by abnormal blood coagulation factors].
Fiedler H
Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
[No Abstract] [Full Text] [Related]
20. [Some recent advances in blood coagulation research].
Sakuragawa N
Rinsho Ketsueki; 1972 Dec; 13(6):923-33. PubMed ID: 4567233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
